Family Medicine

Researchers from the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline will soon launch phase I clinical trials of experimental Ebola vaccines.

Looking back over a 30-year career in pain medicine, the author laments the shift from comprehensive, multidisciplinary pain care to a model that focuses on pills and procedures to treat chronic pain.

Post-traumatic stress disorder and depressive symptoms may be reduced with intravenous ketamine, according to research published in JAMA Psychiatry.

Researchers at ETH Zurich who were studying mice with rheumatoid arthritis found a product that cured the animals of the condition as a precursor to what could be a much larger and beneficial discovery for humans. A statement from the company said the therapy is an "active substance consisting of two fused components."

With more people than ever using cell phones, tablets, and other personal technological devices, dermatologists have voiced concerns over the increase in cases of nickel allergies. Nickel, one of the most prevalent allergens in the United States, can be found within most handheld electronic devices and jewelry.

Although hemodialysis is a commonly used treatment for kidney failure, a recent study has shown it may not be as beneficial for people who develop a sudden case of the condition.

CDC Director Thomas Frieden, MD, visited Liberia to assess ongoing efforts to contain the Ebola outbreak and reported that the current prevention and treatment response has unable to stop the virus from spreading.

When patients seek medical attention for symptoms such as headaches or seizures that could be caused by a range of underlying conditions, the process of arriving at an accurate diagnosis can be quite challenging for health care professionals. One recent study has shown that making the wrong diagnosis in these situations can cause considerable harm.

The nation's youth, and its smoke-free air need federal protection from vapors from e-cigarettes, according to a set of recommendations released Aug. 25 by the American and Heart Association.

Efforts to combat the ongoing Ebola outbreak in West Africa have gone global as Japan recently announced efforts to provide medical assistance to the cause.

Ixekizumab, a drug being evaluated for the treatment of moderate-to-severe chronic plaque psoriasis, continues to demonstrate efficacy and safety in Phase III trials.

Researchers in Great Britain and Australia believe they have found a commonality that could help the treatment of two types of diabetes.

Although HIV-negative gay and bisexual men in committed relationships often cite intimacy as a reason to forgo using condoms, it's also the same reason they use antiretroviral medications to prevent getting HIV.

The intravenous respiratory stimulant GAL-021 is effective in treating opioid-induced respiratory depression, according to the results of a small study.

Patients treated with certolizumab pegol for 24 weeks showed rapid improvement in the signs and symptoms of psoriatic arthritis.

For as much as the Ebola outbreak in West Africa has been in the news lately, a recent survey shows there is still more work to be done when it comes to educating the American public about the risks of the disease.

New research suggests that most patients who have suffered a stroke can be taught to reliably detect the first signs of atrial fibrillation by measuring their peripheral pulse at the radial artery.

Clinicians who treat patients suffering with osteoarthritis pain have a new low-dose nonsteroidal anti-inflammatory drug (NSAID) option at their disposal. Zorvolex (diclofenac) was developed to meet prevailing FDA recommendations regarding NSAID dosing and treatment duration.

Research suggests that patients who develop seemingly temporary cases of atrial fibrillation immediately after most types of surgery are dramatically more likely to suffer subsequent strokes.

The guidelines were developed as part of a multi-part plan to curb misuse, abuse, and diversion of opioid medication by preventing opioid medications from being inappropriately prescribed in the emergency department, and by reducing the overuse of emergency departments for pain relief.

According to the results of a recent study, hospitalized patients may be able to know well in advance whether they are at risk of being diagnosed with type 2 diabetes in the future.

Clinicians may one day be able to offer more effective, personalized treatment to patients diagnosed with lupus thanks to a potential breakthrough in DNA sequencing.

Emergency physicians may see an increase in heroin overdoses that are actually tied to acetyl fentanyl, a legal opiate with effects mirroring heroin.

One-pill regiment includes abacavir, dolutegravir and lamivudine.

Diabetic neuropathic pain can be controlled with a low-fat vegan diet, according to research presented at the American Association of Diabetic Educators Annual Meeting.

Rescheduling hydrocodone combination products to the more-restrictive schedule II will impact clinicians and patients suffering with chronic pain, but will it have the desired effect on the misuse and abuse of these products?

A team of researchers may have identified specific risk factors explaining the association between bipolar disorder and substance abuse among teens.

Patients diagnosed with thyroid disease often use it as an explanation or excuse for neuropsychiatric symptoms; this is a form of "labeling effect."

Infectious disease specialist discusses the intricacies of the deadly virus

When it was approved by the FDA in March 2014, apremilast became the first oral medication approved for the treatment of psoriatic arthritis (PsA). Data from clinical trials showed it to be an effective option for patients, with a safer side effect profile than currently used PsA treatments.